Anna Nikonova

Anna Nikonova

Temple University

H-index: 20

North America-United States

About Anna Nikonova

Anna Nikonova, With an exceptional h-index of 20 and a recent h-index of 17 (since 2020), a distinguished researcher at Temple University, specializes in the field of ADPKD, primary cilium, cancer biology, lung cancer, head and neck cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Indolent Lymphoma: High CR and VGPR Rate with Fixed Duration Bendamustine, Rituximab and Acalabrutinib in Waldenstroms Macroglobulinaemia (BRAWM)

Loss of Pkd1 limits susceptibility to colitis and colorectal cancer

Indolent lymphoma: Bendamustine, rituximab and acalabrutinib in Waldenstroms Macroglobulinemia (BRAWM)

Management of Marginal Zone Lymphoma: A Canadian Perspective

Gaining Wings to FLY: Using Drosophila Oogenesis as an Entry Point for Citizen Scientists in Laboratory Research

Next generation BTK inhibitor acalabrutinib with bendamustine-rituximab in first line waldenstrom's macroglobulinemia: the brawm study

MSI2 regulates VEGFR2 signaling and tumor progression in NSCLC

Loss of Pkd1 limits colorectal cancer by increasing colon barrier function

Anna Nikonova Information

University

Position

Postdoctoral associate at Fox Chase Cancer Center

Citations(all)

1949

Citations(since 2020)

1226

Cited By

1250

hIndex(all)

20

hIndex(since 2020)

17

i10Index(all)

28

i10Index(since 2020)

23

Email

University Profile Page

Google Scholar

Anna Nikonova Skills & Research Interests

ADPKD

primary cilium

cancer biology

lung cancer

head and neck cancer

Top articles of Anna Nikonova

Indolent Lymphoma: High CR and VGPR Rate with Fixed Duration Bendamustine, Rituximab and Acalabrutinib in Waldenstroms Macroglobulinaemia (BRAWM)

Blood

2023/11/28

Loss of Pkd1 limits susceptibility to colitis and colorectal cancer

Oncogenesis

2023/8/5

Indolent lymphoma: Bendamustine, rituximab and acalabrutinib in Waldenstroms Macroglobulinemia (BRAWM)

Hematological Oncology

2023/6

Management of Marginal Zone Lymphoma: A Canadian Perspective

2023/2/1

Anna Nikonova
Anna Nikonova

H-Index: 16

Gaining Wings to FLY: Using Drosophila Oogenesis as an Entry Point for Citizen Scientists in Laboratory Research

2023/1/31

Next generation BTK inhibitor acalabrutinib with bendamustine-rituximab in first line waldenstrom's macroglobulinemia: the brawm study

Blood

2022/11/15

Loss of Pkd1 limits colorectal cancer by increasing colon barrier function

Cancer Research

2022/6/15

NEDD9 sustains hexokinase expression to promote glycolysis

Oncogenesis

2022/4/11

Evaluation of the small-molecule BRD4 degrader CFT-2718 in small-cell lung cancer and pancreatic cancer models

Molecular cancer therapeutics

2021/8/1

Nedd9 controls autophagy to limit non-small cell lung cancer (NSCLC) growth

Cancer Research

2021/7/1

Nedd9 Restrains Autophagy to Limit Growth of Early Stage Non–Small Cell Lung Cancer

Cancer research

2021/7/1

Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)

Oncogenesis

2021/3/15

PKD1 regulates susceptibility to ulcerative colitis and colorectal cancer

Cancer Research

2020/8/15

Patterns of ciliation and ciliary signaling in cancer

2020/8/7

Bendamustine-induced immune hemolytic anemia: a case report and systematic review of the literature

Blood Advances

2020/4/28

Anna Nikonova
Anna Nikonova

H-Index: 16

Katerina Pavenski
Katerina Pavenski

H-Index: 18

Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease

2020/3/1

Synthetic lethal targeting of mitotic checkpoints in HPV-negative head and neck cancer

Cancers

2020/1/28

See List of Professors in Anna Nikonova University(Temple University)

Co-Authors

academic-engine